Publications by Professor Azfar Zaman - ePrints

Browsing publications by Professor Azfar Zaman.

Newcastle Authors	Title	Year
Professor Azfar Zaman	A Randomized, double-blind, dose ranging clinical trial of intravenous FDY-5301 in acute stemi patients undergoing primary PCI	2022
Professor Azfar Zaman	Clinical outcomes according to lesion complexity in high bleeding risk patients treated with 1-month dual antiplatelet therapy following PCI: Analysis from the Onyx ONE clear study	2022
Dr Mohaned Egred Dr Mohammad Alkhalil Professor Azfar Zaman	Coronary revascularization in patients with left ventricle systolic dysfunction, current challenges and clinical outcomes	2022
Stephen Hoole Professor Azfar Zaman	Five-year outcomes after state-of-the-art percutaneous coronary revascularization in patients with de novo three-vessel disease: final results of the SYNTAX II study	2022
Dr Mohaned Egred Professor Azfar Zaman Dr Mohammad Alkhalil	Mechanical circulatory support in acute myocardial infarction complicated by cardiogenic shock	2022
Dr Rajiv Das Dr Richard Edwards Professor Azfar Zaman Dr Mohammad Alkhalil	Prognostic Role of Sex-Specific Flow Threshold in Patients UndergoingTranscatheter Aortic Valve Replacement	2022
Dr Salman Razvi Dr Avais Jabbar Professor Azfar Zaman	Triiodothyronine (T3), inflammation and mortality risk in patients with acute myocardial infarction	2022
Professor Azfar Zaman	ACTIVATION (PercutAneous Coronary inTervention prIor to transcatheter aortic VAlve implantaTION): A Randomized Clinical Trial	2021
Dr Jake McClements Dr Katarina Novakovic Professor Azfar Zaman Professor Ioakim Spyridopoulos Dr Marloes Peeters et al.	Immobilization of Molecularly Imprinted Polymer Nanoparticles onto Surfaces using Different Strategies: Evaluating the Influence of the Functionalised Interface on the Performance of a Thermal Assay for the Detection of Cardiac Biomarker Troponin I	2021
Professor Azfar Zaman Dr Qaiser Aleem	Pharmacology before, during and after percutaneous coronary intervention	2021
Dr Avais Jabbar Lorna Ingoe Dr Shahid Junejo Dr David Austin Professor Azfar Zaman et al.	Prevalence, Predictors and Outcomes of Thyroid Dysfunction in patients with Acute Myocardial Infarction: the ThyrAMI-1 Study	2021
Dr Ben Beska Dr Ashfaq Mohammed Dr Rajiv Das Dr Richard Edwards Professor Azfar Zaman et al.	Role of coronary angiogram before transcatheter aortic valve implantation	2021
Professor Azfar Zaman	Safety and efficacy of Everolimus-Eluting bioabsorbable Polymer-Coated stent in patients with long coronary lesions: The EVOLVE 48 study	2021
Dr Mark De Belder Professor Azfar Zaman	Survival relative to pacemaker status after transcatheter aortic valve implantation	2021
Dr Simon Findlay Professor Azfar Zaman	A comparison of cardiovascular risk scores in native and migrant South Asian populations	2020
Dr Avais Jabbar Lorna Ingoe Dr Shahid Junejo Dr Peter Carey Dr Honey Thomas et al.	Effect of levothyroxine on left ventricular ejection fraction in patients with subclinical hypothyroidism and acute myocardial infarction: a randomized clinical trial	2020
Dr Mohaned Egred Dr Alan Bagnall Professor Ioakim Spyridopoulos Dr Rajiv Das Professor Azfar Zaman et al.	Effect of Pressure-controlled intermittent Coronary Sinus Occlusion (PiCSO) on infarct size in anterior STEMI: PiCSO in ACS study	2020
Professor Azfar Zaman	One-Month dual antiplatelet therapy following percutaneous coronary intervention with zotarolimus-eluting stents in high-bleeding-risk patients	2020
Dr Subhi Akleh Professor Azfar Zaman Dr Rajiv Das Dr Richard Edwards	Outcomes of Direct Flow Medical vs Sapien 3 Transcatheter Aortic Valve Devices	2020
Dr Bilal Bawamia Dr Mohaned Egred Dr Matthew Jackson Dr David Austin Professor Azfar Zaman et al.	Percutaneous coronary intervention for left main stem disease: Impact of diabetes mellitus on mortality	2020
Dr Salman Razvi Dr Avais Jabbar Dr Arjola Bano Lorna Ingoe Dr Peter Carey et al.	Sample Timing, Diagnosis of Subclinical Thyroid Dysfunction and Mortality in Acute Myocardial Infarction: ThyrAMI1 Study	2020
Professor Azfar Zaman Dr Mohaned Egred Dr Alan Bagnall Dr Jannath Ahmed Dr Richard Edwards et al.	Smoking status and mortality outcomes following percutaneous coronary intervention	2020
Professor Azfar Zaman Dr Mark De Belder	Transcatheter aortic valve implantation via surgical subclavian versus direct aortic access: A United Kingdom analysis	2020
Professor Azfar Zaman	Combinations of bleeding and ischemic risk and their association with clinical outcomes in acute coronary syndrome	2019
Professor Azfar Zaman	Outcomes Following Percutaneous Coronary Intervention in Saphenous Vein Grafts With and Without Embolic Protection Devices	2019
Professor Azfar Zaman	Rationale and design of the Onyx ONE global randomized trial: A randomized controlled trial of high-bleeding risk patients after stent placement with 1 month of dual antiplatelet therapy	2019
Professor Azfar Zaman	Safety and efficacy of a sirolimus-eluting coronary stent with ultra-thin strut for treatment of atherosclerotic lesions (TALENT): a prospective multicentre randomised controlled trial	2019
Professor Azfar Zaman	FDXR is a biomarker of radiation exposure in vivo	2018
Professor Azfar Zaman Dr Mohaned Egred Professor Thomas Johnson Dr Mark De Belder	Acute and one-year clinical outcomes following implantation of bioresorbable vascular scaffolds: The ABSORB UK Registry	2018
Professor Azfar Zaman	Orbita – Much ado about nothing?	2018
Dr Sophie Gu Dr Christopher Eggett Dr Hani Ali Professor Azfar Zaman Dr Richard Edwards et al.	Percutaneous Coronary Intervention for Left Ventricular Systolic Dysfunction	2018
Professor Azfar Zaman Dr Qaiser Aleem	Reducing cardiovascular risk in patients with type 2 diabetes mellitus	2018
Dr Matthew Jackson Dr David Austin Muhammad Rashid Dr Mark De Belder Professor Azfar Zaman et al.	The impact of diabetes on the prognostic value of left ventricular function following percutaneous coronary intervention: Insights from the British Cardiovascular Intervention Society	2018
Dr Salman Razvi Dr Avais Jabbar Professor Azfar Zaman	Thyroid Hormones and Cardiovascular Function and Diseases	2018
Dr Mark De Belder Professor Azfar Zaman	Choice of Stent for Percutaneous Coronary Intervention of Saphenous Vein Grafts	2017
Dr Karthik Balasubramaniam Dr Kelvin Lee Muhammad Rashid Professor Azfar Zaman	Mortality after percutaneous coronary revascularization: Prior cardiovascular risk factor control and improved outcomes in patients with diabetes mellitus	2017
Professor Azfar Zaman	Observational Study of Platelet Reactivity in Patients Presenting With ST-Segment Elevation Myocardial Infarction Due to Coronary Stent Thrombosis Undergoing Primary Percutaneous Coronary Intervention: Results From the European PREvention of Stent Thrombosis by an Interdisciplinary Global European Effort Registry	2017
Dr Mark De Belder Professor Azfar Zaman	The Relationship of Body Mass Index to Percutaneous Coronary Intervention Outcomes: Does the Obesity Paradox Exist in Contemporary Percutaneous Coronary Intervention Cohorts? Insights From the British Cardiovascular Intervention Society Registry	2017
Dr Avais Jabbar Professor Simon Pearce Professor Azfar Zaman Dr Salman Razvi	Thyroid hormones and cardiovascular disease	2017
Professor Azfar Zaman	Twelve-month results of a prospective, multicentre trial to assess the everolimus-eluting coronary stent system (PROMUS Element): The PLATINUM PLUS all-comers randomised trial	2017
Dr Mohaned Egred Dr Ayush Khurana Dr Alan Bagnall Professor Azfar Zaman	1-Year Follow-Up Optical Frequency Domain Imaging of Multiple Bioresorbable Vascular Scaffolds for the Treatment of Spontaneous Coronary Artery Dissection	2016
Dr Mark De Belder Professor Azfar Zaman	Changes in Arterial Access Site and Association With Mortality in the United Kingdom: Observations From a National Percutaneous Coronary Intervention Database	2016
Professor Azfar Zaman	Determinants and Outcomes of Stroke Following Percutaneous Coronary Intervention by Indication	2016
Professor Azfar Zaman	Does the Routine Availability of CT-Derived FFR Influence Management of Patients With Stable Chest Pain Compared to CT Angiography Alone?: The FFR_CT RIPCORD Study	2016
Dr Avais Jabbar Dr Ashfaq Mohammed Dr Ayush Khurana Dr Rajiv Das Professor Azfar Zaman et al.	Local versus general anaesthesia in transcatheter aortic valve replacement – a tertiary centre experience	2016
Dr Avais Jabbar Dr Ayush Khurana Dr Ashfaq Mohammed Dr Rajiv Das Professor Azfar Zaman et al.	Local Versus General Anesthesia in Transcatheter Aortic Valve Replacement	2016
Professor Azfar Zaman	Meta-Analysis of the Prognostic Impact of Anemia in Patients Undergoing Percutaneous Coronary Intervention	2016
Dr Mark De Belder Professor Azfar Zaman	Outcomes Following Primary Percutaneous Coronary Intervention in Patients With Previous Coronary Artery Bypass Surgery	2016
Professor Azfar Zaman	P2Y12 receptor inhibitors in patients with non-ST-elevation acute coronary syndrome in the real world: use, patient selection, and outcomes from contemporary European registries	2016
Professor Azfar Zaman	Percutaneous coronary angioplasty versus coronary artery bypass grafting in treatment of unprotected left main stenosis (NOBLE): a prospective, randomised, open-label, non-inferiority trial	2016
Professor Azfar Zaman	Primary percutaneous coronary intervention for ST elevation myocardial infarction in nonagenarians	2016
Dr Avais Jabbar Dr Ayush Khurana Dr Rajiv Das Professor Azfar Zaman Dr Richard Edwards et al.	Transcatheter aortic valve replacement: a comparison of the direct flow medical and sapien 3 aortic valves	2016
Professor Azfar Zaman	Use, patient selection and outcomes of P2Y12 receptor inhibitor treatment in patients with STEMI based on contemporary European registries	2016
Professor Azfar Zaman	Contemporary registries on P2Y12 inhibitors in patients with acute coronary syndromes in Europe: overview and methodological considerations.	2015
Dr Vijay Kunadian Professor Azfar Zaman Dr Mark De Belder	Effect of access site, gender, and indication on clinical outcomes after percutaneous coronary intervention: Insights from the British Cardiovascular Intervention Society (BCIS)	2015
Professor Azfar Zaman	High Platelet Reactivity in Patients with Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention: Randomised Controlled Trial Comparing Prasugrel and Clopidogrel	2015
Professor Bernard Keavney Professor Azfar Zaman Dr Mark De Belder	Impact of age on access site-related outcomes in 469,983 percutaneous coronary intervention procedures: Insights from the British Cardiovascular Intervention Society	2015
Professor Bernard Keavney Professor Azfar Zaman Dr Mark De Belder	Impact of Age on the Prognostic Value of Left Ventricular Function in Relation to Procedural Outcomes Following Percutaneous Coronary Intervention: Insights From the British Cardiovascular Intervention Society	2015
Dr Vijay Kunadian Dr Murugu Veerasamy Dr Hannah Sinclair Dr Rajiv Das Dr Richard Edwards et al.	Major Adverse Cardiovascular Events at 30-days were not Significantly different between Frail and non-frail older ( ≥75 Years) Patients with non ST Elevation Acute Coronary Syndrome Managed by Invasive Strategy: An Analysis from the ICON1 Study	2015
Professor Ioakim Spyridopoulos Dr Javed Ahmed Dr Rajiv Das Dr Richard Edwards Dr Alan Bagnall et al.	Shock-index as a novel predictor of long-term outcome following primary percutaneous coronary intervention	2015
Professor Azfar Zaman Professor Bernard Keavney Dr Mark De Belder	Stroke following percutaneous coronary intervention: type-specific incidence, outcomes and determinants seen by the British Cardiovascular Intervention Society 2007-12	2015
Dr Stephen Boag Dr Rajiv Das Dr Evgeniya Shmeleva Dr Alan Bagnall Dr Mohaned Egred et al.	T lymphocytes and fractalkine contribute to myocardial ischemia/reperfusion injury in patients	2015
Dr Avais Jabbar Professor Simon Pearce Professor Azfar Zaman Dr Salman Razvi	Thyroxine in acute myocardial infarction (ThyrAMI) - levothyroxine in subclinical hypothyroidism post-acute myocardial infarction: study protocol for a randomised controlled trial	2015
Dr Karthik Balasubramaniam Professor Azfar Zaman	Antiplatelet Therapy in Patients Undergoing Primary Percutaneous Coronary Intervention for ST-Elevation Myocardial Infarction: A Retrospective Observational Study of Prasugrel and Clopidogrel	2014
Dr Karthik Balasubramaniam Dr Girish Viswanathan Professor Azfar Zaman	Antithrombotic properties of rafigrelide: a phase 1, open-label, non-randomised, single-sequence, crossover study	2014
Dr Girish Viswanathan Dr Karthik Balasubramaniam Emerita Professor Sally Marshall Professor Azfar Zaman Dr Salman Razvi et al.	Blood Thrombogenicity is Independently Associated with Serum TSH Levels in Post-Non-ST Elevation Acute Coronary Syndrome	2014
Dr Girish Viswanathan Emerita Professor Sally Marshall Dr Karthik Balasubramaniam Professor Azfar Zaman	Differences in thrombus structure and kinetics in patients with type 2 diabetes mellitus after non ST elevation acute coronary syndrome.	2014
Professor Azfar Zaman	Does Routine Pressure Wire Assessment Influence Management Strategy at Coronary Angiography for Diagnosis of Chest Pain? The RIPCORD Study	2014
Dr Stephen Boag Dr Rajiv Das Dr Mohaned Egred Professor Azfar Zaman Dr Alan Bagnall et al.	Dynamic Changes in T-Lymphocyte Counts Following Primary Percutaneous Coronary Intervention Predict Infarct Size and Microvascular Obstruction	2014
Professor Bernard Keavney Professor Azfar Zaman Dr Mark De Belder	Impact of left ventricular function in relation to procedural outcomes following percutaneous coronary intervention: insights from the British Cardiovascular Intervention Society	2014
Dr Murugu Veerasamy Dr Alan Bagnall Professor Azfar Zaman	Multi-vessel coronary artery disease is associated with early, but not late, mortality following primary percutaneous coronary intervention	2014
Dr Vijay Kunadian Dr Bilal Bawamia Professor Azfar Zaman	Outcomes Following Primary Percutaneous Coronary Intervention in the Setting of Cardiac Arrest: A Registry Database Study	2014
Professor Azfar Zaman	Switching from transfemoral to transradial access for PCI: A single-center learning curve over 5 years	2014
Dr Girish Viswanathan Dr Karthik Balasubramaniam Professor Azfar Zaman Emerita Professor Sally Marshall	Thrombogenicity in obese patients with Type 2 diabetes following non ST-elevation acute coronary syndrome: is inflammation the missing link?	2014
Dr Karthik Balasubramaniam Dr Rajiv Das Dr Vijay Kunadian Professor Azfar Zaman	Admission Heart Rate Predicts Mortality Following Primary Percutaneous Coronary Intervention for ST-Elevation Myocardial Infarction	2013
Dr Karthik Balasubramaniam Dr Rajiv Das Dr Vijay Kunadian Professor Azfar Zaman	Admission Heart Rate Predicts Mortality Following Primary Percutaneous Coronary Intervention for ST-Elevation Myocardial Infarction: An Observational Study	2013
Dr Karthik Balasubramaniam Dr Girish Viswanathan Andini Natasari Jessica Tarn Dr Dennis Lendrem et al.	Assessment of blood clot formation and platelet receptor function ex vivo in patients with primary Sjögren’s syndrome	2013
Dr Girish Viswanathan Dr Kathryn White Professor Azfar Zaman Emerita Professor Sally Marshall	Clopidogrel alters thrombus quantity and quality in Type 2 diabetes	2013
Dr Vijay Kunadian Dr Bilal Bawamia Professor Azfar Zaman	Drug eluting stents versus bare metal stents in primary PCI	2013
Dr Vijay Kunadian Dr Bilal Bawamia Dr Murugu Veerasamy Sheila Jamieson Professor Azfar Zaman et al.	Gender Comparisons in Cardiogenic Shock During ST Elevation Myocardial Infarction Treated by Primary Percutaneous Coronary Intervention	2013
Dr Karthik Balasubramaniam Dr Girish Viswanathan Emerita Professor Sally Marshall Dr Salman Razvi Professor Azfar Zaman et al.	Higher Thrombus Burden in Patients with Subclinical Hypothyroidism after Non ST Elevation Acute Coronary Syndrome	2013
Professor Azfar Zaman Dr Javed Ahmed Dr Mohaned Egred Professor Ioakim Spyridopoulos Professor Bernard Keavney et al.	Provision of Gastroprotective Medication and Bleeding Risk Following Acute Coronary Syndrome	2013
Professor Azfar Zaman Dr Javed Ahmed Dr Mohaned Egred Dr Richard Edwards Professor Ioakim Spyridopoulos et al.	Provision of Gastroprotective Medication and Bleeding Risk Following Acute Coronary Syndrome	2013
Dr Girish Viswanathan Dr Karthik Balasubramaniam Dr Bilal Bawamia Emerita Professor Sally Marshall Professor Azfar Zaman et al.	Higher thrombus, altered clot kinetics and fibrin architecture in patients with type 2 diabetes mellitus after non ST elevation acute coronary syndrome	2012
Dr Karthik Balasubramaniam Dr Girish Viswanathan Emerita Professor Sally Marshall Professor Azfar Zaman	Increased atherothrombotic burden in patients with diabetes mellitus and acute coronary syndrome: a review of antiplatelet therapy	2012
Dr Vijay Kunadian Professor Azfar Zaman	Lack of gender difference and improved in-hospital mortality rates in patients with cardiogenic shock following primary percutaneous coronary intervention: a UK tertiary cardiac centre registry study	2012
Dr Vijay Kunadian Professor Azfar Zaman	Lack of gender difference and improved in-hospital mortality rates in patients with cardiogenic shock following primary percutaneous coronary intervention: a UK tertiary cardiac centre registry study	2012
Dr Vijay Kunadian Professor Azfar Zaman	Lack of gender difference and improved in-hospital mortality rates in patients with cardiogenic shock following primary percutaneous coronary intervention: a UK tertiary cardiac centre registry study	2012
Dr Vijay Kunadian Professor Azfar Zaman	Percutaneous coronary intervention among patients with left ventricular systolic dysfunction: a review and meta-analysis of 19 clinical studies	2012
Dr Vijay Kunadian Professor Azfar Zaman	Saphenous vein graft percutaneous coronary intervention via radial artery access: Safe and effective with reduced hospital length of stay	2012
Dr Girish Viswanathan Emerita Professor Sally Marshall Dr Karthik Balasubramaniam Professor Azfar Zaman	Thrombus and antiplatelet therapy in type 2 diabetes mellitus: A prospective study after non-ST elevation acute coronary syndrome and a randomised, blinded, placebo-controlled study in stable angina	2012
Dr Girish Viswanathan Professor Azfar Zaman	Unfractionated Heparin during Elective PCI: Fixed Dose or Weight Adjusted?	2012
Professor Azfar Zaman	Changing Characteristics and Mode of Death Associated With Chronic Heart Failure Caused by Left Ventricular Systolic Dysfunction A Study Across Therapeutic Eras	2011
Dr Bilal Bawamia Sheila Jamieson Professor Azfar Zaman	Evaluating a nurse led triage process in treating patients with left bundle branch block (LBBB) referred for primary percutaneous coronary intervention (pPCI)	2011
Dr Bilal Bawamia Sheila Jamieson Professor Azfar Zaman	Evaluating a nurse-led triage process in treating patients with Left Bundle Branch Block (LBBB) referred for primary Percutaneous Coronary Intervention (pPCI)	2011
Dr Bilal Bawamia Sheila Jamieson Professor Azfar Zaman	Evaluating a nurse-led triage process in treating patients with Left Bundle Branch Block (LBBB) referred for primary Percutaneous Coronary Intervention (pPCI)	2011
Dr Girish Viswanathan Anthony Hildreth Professor Azfar Zaman	Health Related Quality of Life After Percutaneous Coronary Revascularisation in Patients with Previous Coronary Artery Bypass Grafts: A Two-Year Follow Up Study	2011
Dr Vijay Kunadian Professor Azfar Zaman	Revascularization among patients with severe left ventricular dysfunction: a meta-analysis of observational studies	2011
Dr Vijay Kunadian Professor Azfar Zaman Professor Ioakim Spyridopoulos	Sodium bicarbonate for the prevention of contrast induced nephropathy: A meta-analysis of published clinical trials	2011
Dr Girish Viswanathan Professor Azfar Zaman	Better clinical outcomes of participants in clinical research: Trial effect of an observational study in patients with non ST elevation acute coronary syndrome (NSTE-ACS)	2010
Professor Azfar Zaman Dr Asif Shah	Changing Characteristics and Outcomes of Patients with Chronic Heart Failure due to Left Ventricular Systolic Dysfunction: a Study Across Therapeutic Eras	2010
Dr Girish Viswanathan Emerita Professor Sally Marshall Professor Azfar Zaman	Evaluation of Thrombus in Patients with Type 2 Diabetes Mellitus After Non-ST-Elevation Acute Coronary Syndrome (NSTE-ACS): Increased Amount and Altered Strength	2010
Dr Girish Viswanathan Dr Arun Natarajan Emerita Professor Sally Marshall Professor Azfar Zaman	Higher Thrombus Burden and Impaired Clot Kinetics in Patients with Type 2 Diabetes Mellitus following Non ST-Elevation Acute Coronary Syndrome	2010
Dr Girish Viswanathan Emerita Professor Sally Marshall Professor Azfar Zaman	Thrombus burden and response to clopidogrel in patients with type 2 diabets mellitus presenting with non ST elevation acute coronary syndrome	2010
Professor Azfar Zaman Emeritus Professor David Mendelow Dr Daniel Birchall	Analysis of haemodynamic factors involved in carotid atherosclerosis using computational fluid dynamics	2009
Dr Sharad Agarwal Professor Azfar Zaman	Assessment of functional status and quality of life after percutaneous coronary revascularisation in octogenarians	2009
Dr Girish Viswanathan Sajid Javed Sheila Jamieson Professor Azfar Zaman	Guidelines to Practice Gap in the Use of Glycoprotein IIb/IIIa Inhibitors: From ISAR-REACT to Overreact ?	2009
Dr Honey Thomas Dr Peter Avery Dr Javed Ahmed Dr Richard Edwards Professor Azfar Zaman et al.	Local vessel injury following percutaneous coronary intervention does not promote early mobilisation of endothelial progenitor cells in the absence of myocardial necrosis	2009
Dr Arun Natarajan Professor Azfar Zaman	Non-invasive assessment of saphenous vein graft patency in asymptomatic patients	2009
Professor Azfar Zaman	Percutaneous coronary intervention in anticoagulated patients via radial artery access	2009
Professor Azfar Zaman	Radial artery anomaly and its influence on transradial coronary procedural outcome	2009
Dr Vijay Kunadian Professor Azfar Zaman	Sodium Bicarbonate For The Prevention Of Contrast Induced Nephropathy: A Meta-Analysis	2009
Professor Azfar Zaman	Transradial coronary angiography in children and adolescents	2009
Professor Azfar Zaman	Comparison of operator radiation exposure with optimized radiation protection devices during coronary angiograms and ad hoc percutaneous coronary interventions by radial and femoral routes	2008
Dr Vijay Kunadian Professor Azfar Zaman	Malignancy: An unrecognized risk factor for coronary stent thrombosis?	2008
Dr Arun Natarajan Professor Azfar Zaman Emerita Professor Sally Marshall	Platelet hyperactivity in type 2 diabetes: Role of antiplatelet agents	2008
Dr Arun Natarajan Emerita Professor Sally Marshall Professor Azfar Zaman	The presence of coronary artery disease increases platelet-dependent thrombosis in patients with type 2 diabetes mellitus	2008
Dr Arun Natarajan Professor Azfar Zaman	Antiplatelet therapy in acute coronary syndromes	2007
Professor Azfar Zaman	Incidence of radial artery anatomic variation in patients undergoing transradial coronary angiography and intervention: Influence on procedural outcome.	2007
Professor Azfar Zaman	Incidence of radial artery anatomical variation in patients undergoing transradial coronary angiography and intervention: Influence on procedural outcome	2007
Professor Azfar Zaman	Percutaneous Coronary Revascularization Reduces Plasma N-Terminal Pro-B-Type Natriuretic Peptide Concentration in Stable Coronary Artery Disease	2007
Dr Arun Natarajan Professor Azfar Zaman	Thrombogenicity in type 2 diabetes and coronary artery disease	2007
Dr Daniel Birchall Professor Azfar Zaman Emeritus Professor David Mendelow	Analysis of haemodynamic disturbance in the atherosclerotic carotid artery using computational fluid dynamics	2006
Dr Arun Natarajan Emerita Professor Sally Marshall Professor Azfar Zaman	Blood thrombogenicity is increased in patients with type 2 diabetes mellitus and stable coronary artery disease despite aspirin and statin therapy	2006
Professor Azfar Zaman	Drug Insight: Antithrombotic therapy after percutaneous coronary intervention in patients with an indication for anticoagulation	2006
Dr Arun Natarajan Emerita Professor Sally Marshall Professor Azfar Zaman	Patients with type 2 diabetes mellitus have higher thrombogenicity despite aspirin and statin therapy	2005
Dr Arun Natarajan Emerita Professor Sally Marshall Dr John Hanley Professor Azfar Zaman	Thrombogenicity of flowing blood is increased in patients with type 2 diabetes mellitus (T2DM) despite treatment with aspirin	2005
Professor Azfar Zaman	Angiotensin-converting enzyme inhibitors as adjunctive therapy in patients with persistent atrial fibrillation	2004
Dr Ewan Shepherd Dr Chris Plummer Professor Azfar Zaman Dr Janet McComb	Mortality and symptom benefit with cardiac resynchronisation therapy (CRT) in severe heart failure	2004
Professor Azfar Zaman	Predicting sudden death in patients with mild to moderate chronic heart failure	2004
Anthony Hildreth Dr Dominic Cox Professor Azfar Zaman	Quality of life after percutaneous coronary intervention for patients with previous coronary artery bypass grafting	2004
Professor Azfar Zaman	A prognostic index to predict long-term mortality in patients with mild to moderate chronic heart failure stabilised on angiotensin converting enzyme inhibitors	2003
Professor Azfar Zaman	Coronary angioplasty versus fibrinolytic therapy in acute myocardial infarction	2003
Professor Azfar Zaman Dr Asif Shah	Mortality, autonomic and myocardial abnormalities in chronic heart failure patients with markedly prolonged ventricular activation	2002
Professor Azfar Zaman	Predicting death due to progressive heart failure in patients with mild-to-moderate chronic heart failure	2002
Professor Azfar Zaman	Progression and Regression of Atherosclerotic Lesions Monitoring With Serial Noninvasive Magnetic Resonance Imaging	2002
Professor Azfar Zaman	Blood thrombogenicity in type 2 diabetes mellitus patients is associated with glycemic control	2001
Professor Azfar Zaman	Implementation of the NICE guidelines for the primary prevention of mortality from ventricular tachyarrhythmias: implications for UK electrophysiology centres; activity modelling from the UK-HEART study	2001